Cited by 652Schizophrenia research and treatmentNeurotransmitter Receptor Influence on BehaviorNeural and Behavioral Psychology Studies

The DOI matches its Crossref record; 50 of the 50 references it cites were found in a registry or an index.

Reduced prefrontal activity predicts exaggerated striatal dopaminergic function in schizophrenia

Meyer-Lindenberg, Andreas, Miletich, Robert S., Kohn, Philip D., Esposito, Giuseppe, Carson, Richard E., Quarantelli, Mario, Weinberger, Daniel R., Berman, Karen Faith·2002·Nature Neuroscience

DOI 10.1038/nn804

Open this paper in CoChat — free account

Abstract

Both dopaminergic neurotransmission and prefrontal cortex (PFC) function are known to be abnormal in schizophrenia. To test the hypothesis that these phenomena are related, we measured presynaptic dopaminergic function simultaneously with regional cerebral blood flow during the Wisconsin Card Sorting Test (WCST) and a control task in unmedicated schizophrenic subjects and matched controls. We show that the dopaminergic uptake constant Ki in the striatum was significantly higher for patients than for controls. Patients had significantly less WCST-related activation in PFC. The two parameters were strongly linked in patients, but not controls. The tight within-patient coupling of these values, with decreased PFC activation predicting exaggerated striatal 6-fluorodopa uptake, supports the hypothesis that prefrontal cortex dysfunction may lead to dopaminergic transmission abnormalities.

Integrity signals

Registry

Crossref · 10.1038/nn804

Cites

50 of 50 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Co-Planar Stereotaxic Atlas of the Human Brain
Talairach, J., & Tournoux, P. (1988) · Medical Entomology and Zoology · Cited by 11,798
Co-planar stereotaxic atlas of the human brain
Laitinen, L. (1989) · Clinical Neurology and Neurosurgery · doi:10.1016/0303-8467(89)90128-5 · Cited by 7,565
Implications of Normal Brain Development for the Pathogenesis of Schizophrenia
Weinberger, D. R. (1987) · Archives of General Psychiatry · doi:10.1001/archpsyc.1987.01800190080012 · Cited by 3,724
Self-citation
Graphical Evaluation of Blood-to-Brain Transfer Constants from Multiple-Time Uptake Data
Patlak, C. S., Blasberg, R. G., & Fenstermacher, J. D. (1983) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.1983.1 · Cited by 3,565
Dementia Praecox and Paraphrenia.
(1972) · Annals of Internal Medicine · doi:10.7326/0003-4819-76-6-1058_8 · Cited by 2,907
Physiologic Dysfunction of Dorsolateral Prefrontal Cortex in Schizophrenia
Weinberger, D. R. (1986) · Archives of General Psychiatry · doi:10.1001/archpsyc.1986.01800020020004 · Cited by 2,025
Self-citation
Phasic versus tonic dopamine release and the modulation of dopamine system responsivity: A hypothesis for the etiology of schizophrenia
Grace, A. A. (1991) · Neuroscience · doi:10.1016/0306-4522(91)90196-u · Cited by 1,831
MRI-PET Registration with Automated Algorithm
Woods, R. P., Mazziotta, J. C., & Cherry, A. S. R. (1993) · Journal of Computer Assisted Tomography · doi:10.1097/00004728-199307000-00004 · Cited by 1,636
Positron-emission tomography
Ollinger, J. M., & Fessler, J. A. (1997) · IEEE Signal Processing Magazine · doi:10.1109/79.560323 · Cited by 1,168
Increased baseline occupancy of D 2 receptors by dopamine in schizophrenia
Abi-Dargham, A., Rodenhiser, J., Printz, D., Zea-Ponce, Y., Gil, R., Kegeles, L. S., Weiss, R., Cooper, T. B., Mann, J. J., Van Heertum, R. L., et al. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.14.8104 · Cited by 1,020

Flagged first, then by citations

Show all 50 references

Research works printed but not linked: 1

Kraepelin, E., Barclay, R. M. & Robertson, G. M. Dementia Præcox and Paraphrenia (E. & S. Livingstone, Edinburgh, 1919).

Sorted by citations

Items 401–500 of 646

Decision-Making, Behavioral Supervision and Learning: An Executive Role for the Ventral Premotor Cortex?
Acuña, C., Pardo‐Vázquez, J. L., & Leborán, V. (2010) · Neurotoxicity Research · doi:10.1007/s12640-010-9194-y · Cited by 19
F-18Fluorodeoxyglucose positron emission tomography studies of the schizophrenia spectrum: The legacy of Monte S. Buchsbaum, M.D.
Hazlett, E. A., Vaccaro, D. H., Haznedar, M. M., & Goldstein, K. E. (2018) · Psychiatry Research · doi:10.1016/j.psychres.2018.12.030 · Cited by 19
Stimulation of group I mGlu receptors in the ventrotegmental area enhances extracellular dopamine in the rat medial prefrontal cortex
Renoldi, G., Calcagno, E., Borsini, F., & Invernizzi, R. W. (2006) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2006.04317.x · Cited by 19
The Enduring Centrality of Dopamine in the Pathophysiology of Schizophrenia
Bonoldi, I., & Howes, O. D. (2013) · Advances in pharmacology · doi:10.1016/b978-0-12-411512-5.00010-5 · Cited by 19
COMT Val158Met Polymorphism Modulates Huntington's Disease Progression
de Diego‐Balaguer, R., Schramm, C., Cournu‐Rebeix, I., Emmanuel Dupoux, A., Dürr, A., Brice, A., Charles, P., de Langavant, L. C., Youssov, K., Verny, C., et al. (2016) · PLoS ONE · doi:10.1371/journal.pone.0161106 · Cited by 18
The effect of a genetic variant at the schizophrenia associated AS3MT/BORCS7 locus on striatal dopamine function: A PET imaging study
D’Ambrosio, E., Dahoun, T., Pardiñas, A. F., Veronese, M., Bloomfield, M., Jauhar, S., Bonoldi, I., Rogdaki, M., Froudist‐Walsh, S., Walters, J., et al. (2019) · Psychiatry Research Neuroimaging · doi:10.1016/j.pscychresns.2019.07.005 · Cited by 19
The Impact of Psychosis on Sexual Functioning: A Systematic Review
Vargas-Cáceres, S., Cera, N., Nobre, P. J., & Ramos‐Quiroga, J. A. (2021) · The Journal of Sexual Medicine · doi:10.1016/j.jsxm.2020.12.007 · Cited by 20
Neurochemical Imaging in Schizophrenia
Urban, N., & Abi‐Dargham, A. (2010) · Current topics in behavioral neurosciences · doi:10.1007/7854_2010_37 · Cited by 18
A computer-based quantitative systems pharmacology model of negative symptoms in schizophrenia: exploring glycine modulation of excitation-inhibition balance
Spiros, Ä., Roberts, P., & Geerts, H. (2014) · Frontiers in Pharmacology · doi:10.3389/fphar.2014.00229 · Cited by 18
Neural Correlates of Interval Timing Deficits in Schizophrenia
Snowden, A. W., & Buhusi, C. V. (2019) · Frontiers in Human Neuroscience · doi:10.3389/fnhum.2019.00009 · Cited by 18
Association Study of a Functional MAOA-uVNTR Gene Polymorphism and Cognitive Function in Healthy Females
Yu, Y. W. ‐., Tsai, S., Hong, C., Chen, M., Yang, C., & Chen, T. (2005) · Neuropsychobiology · doi:10.1159/000086609 · Cited by 18
Cannabinoids for the Treatment of Schizophrenia? A Balanced Neurochemical Framework for Both Adverse and Therapeutic Effects of Cannabis Use
Coulston, C. M., Perdices, M., Henderson, A. F., & Malhi, G. S. (2010) · Schizophrenia Research and Treatment · doi:10.1155/2011/501726 · Cited by 18
Does dopamine sensitization underlie the association between schizophrenia and drug abuse?
Tsapakis, E., Guillin, O., & Murray, R. (2003) · Current Opinion in Psychiatry · doi:10.1097/00001504-200304002-00008 · Cited by 22
Functional Imaging Research in Schizophrenia
Tost, H., Ende, G., Ruf, M., Henn, F. A., & Meyer‐Lindenberg, A. (2005) · International review of neurobiology · doi:10.1016/s0074-7742(05)67004-3 · Cited by 18
Self-citation
Standardized Data Acquisition for Neuromelanin-sensitive Magnetic Resonance Imaging of the Substantia Nigra
Salzman, G., Kim, J., Horga, G., & Wengler, K. (2021) · Journal of Visualized Experiments · doi:10.3791/62493 · Cited by 18
Simultaneous fMRI and fast-scan cyclic voltammetry bridges evoked oxygen and neurotransmitter dynamics across spatiotemporal scales
Walton, L. R., Verber, M., Lee, S.-H., Chao, T.-H. H., Wightman, R. M., & Shih, Y. I. (2021) · NeuroImage · doi:10.1016/j.neuroimage.2021.118634 · Cited by 18
D2/D3 dopamine receptor binding with [F-18]fallypride correlates of executive function in medication-naïve patients with schizophrenia
Vyas, N. S., Buchsbaum, M. S., Lehrer, D. S., Merrill, B., DeCastro, A., Doninger, N. A., Christian, B. T., & Mukherjee, J. (2017) · Schizophrenia Research · doi:10.1016/j.schres.2017.05.017 · Cited by 17
Biological Psychiatry and Psychopharmacology
Fountoulakis, K. N., Nimatoudis, I., & Stahl, S. M. (2019) · Springer eBooks · doi:10.1007/978-3-030-18323-3_13 · Cited by 17
Potential Clinical Targets of Repetitive Transcranial Magnetic Stimulation Treatment in Schizophrenia
Cordes, J., Arends, M., Mobascher, A., Brinkmeyer, J., Kornischka, J., Eichhammer, P., Klimke, A., Winterer, G., & Agelink, M. W. (2006) · Neuropsychobiology · doi:10.1159/000096990 · Cited by 17
PET Imaging in Psychiatric Disorders
Ferrando, R., Hernandes, D., Ghini, B. G., & Coutinho, A. M. (2025) · Seminars in Nuclear Medicine · doi:10.1053/j.semnuclmed.2025.06.004 · Cited by 20
Copy number deletion burden is associated with cognitive, structural, and resting-state network differences in patients with schizophrenia
Martin, A. K., Robinson, G. A., Reutens, D. C., & Mowry, B. J. (2014) · Behavioural Brain Research · doi:10.1016/j.bbr.2014.07.002 · Cited by 16
Dopamine, Cognitive Flexibility, and IQ: Epistatic Catechol-O-MethylTransferase:DRD2 Gene–Gene Interactions Modulate Mental Rigidity
Zmigrod, L., & Robbins, T. W. (2021) · Journal of Cognitive Neuroscience · doi:10.1162/jocn_a_01784 · Cited by 17
Similarities in the behavior and molecular deficits in the frontal cortex between the neurotensin receptor subtype 1 knockout mice and chronic phencyclidine-treated mice: Relevance to schizophrenia
Li, Z., Boules, M., Williams, K., Gordillo, A., Li, S., & Richelson, E. (2010) · Neurobiology of Disease · doi:10.1016/j.nbd.2010.07.011 · Cited by 18
D1 receptor antagonist-induced long-term depression in the medial prefrontal cortex of rat, in vivo: an animal model of psychiatric hypofrontality
Coppa-Hopman, R., Galle, J., & Pimkine, D. (2008) · Journal of Psychopharmacology · doi:10.1177/0269881108091256 · Cited by 15
Understanding responder neurobiology in schizophrenia using a quantitative systems pharmacology model: Application to iloperidone
Geerts, H., Roberts, P., Spiros, Ä., & Potkin, S. G. (2015) · Journal of Psychopharmacology · doi:10.1177/0269881114568042 · Cited by 15
PET Measurement of rCBF in the presence of a neurochemical tracer.
Converse, A., Barnhart, T., Dabbs, K., Dejesus, O., Larson, J. A., Nickles, R., Schneider, M., & Roberts, A. (2004) · Journal of Neuroscience Methods · doi:10.1016/j.jneumeth.2003.09.006 · Cited by 16
A 4-year dopamine transporter (DAT) imaging study in neuroleptic-naive first episode schizophrenia patients
Mané, A., Gallego, J., Lomeña, F., Mateos, J. J., Fernández-Egea, E., Horga, G., Cot, A., Pavı́a, J., Bernardo, M., & Parellada, E. (2011) · Psychiatry Research Neuroimaging · doi:10.1016/j.pscychresns.2011.03.004 · Cited by 15
Kappa Opioid Receptors Mediate Heterosynaptic Suppression of Hippocampal Inputs in the Rat Ventral Striatum
Brooks, J. M., & O’Donnell, P. (2017) · Journal of Neuroscience · doi:10.1523/jneurosci.0876-17.2017 · Cited by 15
Schizophrenia-Like Behavioral Impairments in Mice with Suppressed Expression of Piccolo in the Medial Prefrontal Cortex
Nitta, A., Izuo, N., Hamatani, K., Inagaki, R., Kusui, Y., Fu, K., Asano, T., Torii, Y., Habuchi, C., Sekiguchi, H., et al. (2021) · Journal of Personalized Medicine · doi:10.3390/jpm11070607 · Cited by 15
Clinical correlation but no elevation of striatal dopamine synthesis capacity in two independent cohorts of medication-free individuals with schizophrenia
Eisenberg, D. P., Kohn, P. D., Hegarty, C. E., Smith, N. R., Grogans, S. E., Czarapata, J. B., Gregory, M. D., Apud, J. A., & Berman, K. F. (2021) · Molecular Psychiatry · doi:10.1038/s41380-021-01337-1 · Cited by 17
Self-citation
Aberrant functioning of the putamen links delusions, antipsychotic drug dose, and compromised connectivity in first episode psychosis—Preliminary fMRI findings
Raij, T. T., Mäntylä, T. J. S., Kieseppä, T., & Suvisaari, J. (2015) · Psychiatry Research Neuroimaging · doi:10.1016/j.pscychresns.2015.06.008 · Cited by 15
Schizophrenia and Substance Abuse Co-Morbidity
O’Daly, O., Guillin, O., Tsapakis, E.-M., Martínez, D., Shergill, S. S., Murray, R. M., & Buckley, P. F. (2005) · Journal of Dual Diagnosis · doi:10.1300/j374v01n02_03 · Cited by 15
Pharmacogenomics of psychiatric drug treatment
Pickar, D. (2003) · Psychiatric Clinics of North America · doi:10.1016/s0193-953x(02)00109-0 · Cited by 15
Why psychosis is frequently associated with Parkinson's disease?
Zhong, J., Wu, S., Zhao, Y. H., Chen, H., Zhao, N.-W., Zheng, K.-W., Zhao, Z., Chen, W. K., Wang, B., & Wu, K. (2013) · PubMed Central · doi:10.3969/j.issn.1673-5374.2013.27.006 · Cited by 14
Phospholipase C-β1 Hypofunction in the Pathogenesis of Schizophrenia
Kim, S.-W., Cho, T., & Lee, S. (2015) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2015.00159 · Cited by 14
A polygenic score indexing a DRD2-related co-expression network is associated with striatal dopamine function
D’Ambrosio, E., Pergola, G., Pardiñas, A. F., Dahoun, T., Veronese, M., Sportelli, L., Taurisano, P., Griffiths, K., Jauhar, S., Rogdaki, M., et al. (2022) · Scientific Reports · doi:10.1038/s41598-022-16442-6 · Cited by 14
Multi-locus association study of schizophrenia susceptibility genes with a posterior probability method
Sun, X.-Q., Jia, Y.-B., Zhang, X.-G., Xu, Q., Shen, Y., & Li, Y.-D. (2005) · Science in China Series C Life Sciences · doi:10.1007/bf03183620 · Cited by 13
Imaging as Tool to Investigate Psychoses and Antipsychotics
Booij, J., & van Amelsvoort, T. (2012) · Handbook of experimental pharmacology · doi:10.1007/978-3-642-25761-2_12 · Cited by 14
Neonatal basolateral amygdala lesions affect monoamine and cannabinoid brain systems in adult rats
Bouwmeester, H., Gerrits, M. A. F. M., Roozemond, J. G., Snapper, J., Ronken, E., Kruse, C. G., Westenberg, H. G. M., & van Ree, J. M. (2006) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145706007346 · Cited by 14
Investigational drugs for schizophrenia targeting the dopamine receptor: Phase II trials
Rao, N. P., & Remington, G. J. (2013) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.2013.795945 · Cited by 13
Hypofunction of prefrontal cortex NMDA receptors does not change stress-induced release of dopamine and noradrenaline in amygdala but disrupts aversive memory
Arco, A. D., Ronzoni, G., & Mora, F. (2015) · Psychopharmacology · doi:10.1007/s00213-015-3894-1 · Cited by 13
Impaired heme metabolism in schizophrenia-derived cell lines and in a rat model of the disorder: Possible involvement of mitochondrial complex I
Ifhar, L. S., Ene, H. M., & Ben‐Shachar, D. (2019) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2019.03.011 · Cited by 13
Increased resting-state interhemispheric functional connectivity of striatum in first-episode drug-naive adolescent-onset schizophrenia
Yang, G., Zhang, S., Zhou, Y., Song, Y., Hu, W., Peng, Y., Shi, H., & Zhang, Y. (2022) · Asian Journal of Psychiatry · doi:10.1016/j.ajp.2022.103134 · Cited by 13
The impact of monetary reward on memory in schizophrenia spectrum disorder.
Thornton, A. E., Boudreau, V. G., Griffiths, S. Y., Woodward, T. S., Fawkes-Kirby, T., & Honer, W. G. (2007) · Neuropsychology · doi:10.1037/0894-4105.21.5.631 · Cited by 14
Dopamine sensing by fluorescent carbon nanoparticles synthesized using artichoke extract
Puglisi, R., Mancuso, L. M., Santonocito, R., Gulino, A., Oliveri, V., Ruffino, R., Destri, G. L., Muccilli, V., Cardullo, N., Tuccitto, N., et al. (2024) · Journal of Materials Chemistry B · doi:10.1039/d4tb00651h · Cited by 12
Neurodegenerative Aspects in Vulnerability to Schizophrenia Spectrum Disorders
Archer, T., Ricci, S., Garcia, D., & Ricciardi, M. R. (2014) · Neurotoxicity Research · doi:10.1007/s12640-014-9473-0 · Cited by 14
The Relationship Between Frontostriatal Connectivity and Striatal Dopamine Function in Schizophrenia: An 18F-DOPA PET and Diffusion Tensor Imaging Study in Treatment Responsive and Resistant Patients
Shin, S. H., Jung, W. H., McCutcheon, R. A., Veronese, M., Beck, K., Lee, J., Lee, Y., Howes, O. D., Kim, E., & Kwon, J. S. (2022) · Psychiatry Investigation · doi:10.30773/pi.2022.0033 · Cited by 12
Phenotypic Screening of the Prestwick Library for Treatment of Parkinson's Tremor Symptoms using a Humanized Quantitative Systems Pharmacology Platform
Spiros, Ä., Roberts, P., & Geerts, H. (2013) · Journal of Parkinson s Disease · doi:10.3233/jpd-130211 · Cited by 12
Pharmacologic Treatment of First-Episode Schizophrenia
Thomas, S. P., Nandhra, H. S., & Singh, S. P. (2012) · The Primary Care Companion For CNS Disorders · doi:10.4088/pcc.11r01198 · Cited by 12
Altered mesocorticolimbic functional connectivity in psychotic disorder: an analysis of proxy genetic and environmental effects
Peeters, S. C. T., Gronenschild, E. H. B. M., van de Ven, V. G., Habets, P., Goebel, R., van Os, J., Marcelis, M. C., & (G.R.O.U.P.), F. G. R. A. O. O. P. (2015) · Psychological Medicine · doi:10.1017/s0033291715000161 · Cited by 12
Semi-mechanistic computer simulation of psychotic symptoms in schizophrenia with a model of a humanized cortico-striatal-thalamocortical loop
Spiros, Ä., Roberts, P., & Geerts, H. (2017) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2016.12.006 · Cited by 12
Toward a revised theory of general intelligence: Further examination of fluid cognitive abilities as unique aspects of human cognition
Blair, C. (2006) · Behavioral and Brain Sciences · doi:10.1017/s0140525x06419038 · Cited by 13
A Guide to the Genetics of Psychiatric Disease
Hough, C. J., & Ursano, R. J. (2006) · Psychiatry · doi:10.1521/psyc.2006.69.1.1 · Cited by 12
Model-based parametric study of frontostriatal abnormalities in schizophrenia patients
Tanaka, S. (2010) · BMC Psychiatry · doi:10.1186/1471-244x-10-17 · Cited by 12
Genetische und medikamentöse Einflüsse auf die Funktion des präfrontalen Kortex bei schizophrenen Patienten
Heinz, A., Braus, D. F., Romero, B., Gallinat, J., Puls, I., Juckel, G., & Weinberger, D. R. (2004) · Der Nervenarzt · doi:10.1007/s00115-004-1713-8 · Cited by 12
Self-citation
Dopamine and Schizophrenia
Abi‐Dargham, A., & Grace, A. A. (2010) · Wiley eBooks · doi:10.1002/9781444327298.ch20 · Cited by 12
Altered brain functional networks in schizophrenia with persistent negative symptoms: an activation likelihood estimation meta-analysis
Zhu, T., Wang, Z., Wu, W., Ling, Y., Wang, Z., Zhou, C., Fang, X., Huang, C., Xie, C., Chen, J., et al. (2023) · Frontiers in Human Neuroscience · doi:10.3389/fnhum.2023.1204632 · Cited by 11
DNA methylome perturbations: an epigenetic basis for the emergingly heritable neurodevelopmental abnormalities associated with maternal smoking and maternal nicotine exposure
Buck, J. M., Yu, L., Knopik, V. S., & Stitzel, J. A. (2021) · Biology of Reproduction · doi:10.1093/biolre/ioab138 · Cited by 11
Dopamine Receptors and the Treatment of Schizophrenia
Ginovart, N., & Kapur, S. (2009) · The Receptors · doi:10.1007/978-1-60327-333-6_16 · Cited by 11
No difference in frontal cortical activity during an executive functioning task after acute doses of aripiprazole and haloperidol
Bolstad, I., Andreassen, O. A., Groote, I. R., Haatveit, B. C., Server, A., & Jensen, J. (2015) · Frontiers in Human Neuroscience · doi:10.3389/fnhum.2015.00296 · Cited by 11
Fluphenazine (oral) versus placebo for schizophrenia
Matar, H. E., Almerie, M. Q., & Sampson, S. J. (2018) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd006352.pub3 · Cited by 11
Protocol for evaluation of neurotrophic strategies in Parkinson
Hegarty, S. V., Sullivan, A. M., & O’Keeffe, G. W. (2016) · Journal of Biological Methods · doi:10.14440/jbm.2016.124 · Cited by 11
Modeling excess striatal D2 receptors in mice
Kellendonk, C. (2009) · Progress in Brain Research · doi:10.1016/s0079-6123(09)17907-4 · Cited by 10
Interrelations between dopaminergic-, gabaergic- and glutamatergic neurotransmitters in antipsychotic-naïve psychosis patients and the association to initial treatment response
Bojesen, K. B., Ambrosen, K. S., Sigvard, A. K., Nielsen, M. Ø., GJEDDE, A. H., Kumakura, Y., Jensen, L. T., Fuglø, D., Ebdrup, B. H., Rostrup, E., et al. (2025) · Molecular Psychiatry · doi:10.1038/s41380-025-03229-0 · Cited by 10
Hypothesis of subcortical visual pathway impairment in schizophrenia
Shen, L., Liu, D., & Huang, Y. (2021) · Medical Hypotheses · doi:10.1016/j.mehy.2021.110686 · Cited by 11
Altered netrin‐1 receptor expression in dopamine terminal regions following neonatal ventral hippocampal lesions in the rat
Flores, C., Bhardwaj, S. K., Labelle‐Dumais, C., & Srivastava, L. K. (2008) · Synapse · doi:10.1002/syn.20584 · Cited by 10
Diabète et antipsychotiques de seconde génération
Chabroux, S., Haffen, É., & Penfornis, A. (2009) · Annales d Endocrinologie · doi:10.1016/j.ando.2009.07.003 · Cited by 10
The audacity of proteomics: a chance to overcome current challenges in schizophrenia research
Baloyianni, N. V., & Tsangaris, G. T. (2009) · Expert Review of Proteomics · doi:10.1586/epr.09.85 · Cited by 10
Postnatal Neurogenesis and Dopamine Alterations in Early Psychosis
Inta, D., Lima‐Ojeda, J. M., Gass, P., & Fusar‐Poli, P. (2012) · Recent Patents on CNS Drug Discovery · doi:10.2174/157488912803251998 · Cited by 10
Altered brainstem responses to modafinil in schizophrenia: implications for adjunctive treatment of cognition
Minzenberg, M., Yoon, J. H., Soosman, S. K., & Carter, C. S. (2018) · Translational Psychiatry · doi:10.1038/s41398-018-0104-z · Cited by 10
Cortical dopamine dysregulation in schizophrenia and its link to stress
Gomes, F. V., & Grace, A. A. (2018) · Brain · doi:10.1093/brain/awy156 · Cited by 10
Can PET/CT imaging advance our understanding of the neurobiology of schizophrenia?
Vyas, N. S., Patel, N., Nijran, K. S., AL-NAHHAS, A. M., & Puri, B. K. (2009) · Nuclear Medicine Communications · doi:10.1097/mnm.0b013e3283341830 · Cited by 10
Fluphenazine (oral) versus placebo for schizophrenia
Matar, H. E., & Almerie, M. Q. (2007) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd006352 · Cited by 10
How have developments in molecular imaging techniques furthered schizophrenia research?
Thompson, J. L., Urban, N., & Abi‐Dargham, A. (2009) · Imaging in Medicine · doi:10.2217/iim.09.22 · Cited by 9
Ramping activity in the striatum
Ponzi, A. P. D., & Wickens, J. R. (2022) · Frontiers in Computational Neuroscience · doi:10.3389/fncom.2022.902741 · Cited by 10
10 Hz repetitive transcranial magnetic stimulation (rTMS) may improve cognitive function: An exploratory study of schizophrenia patients with auditory hallucinations
Mao, J., Fan, K., Zhang, Y., Wen, N., Fang, X., Ye, X., & Chen, Y. (2023) · Heliyon · doi:10.1016/j.heliyon.2023.e19912 · Cited by 9
Intra-individual variability and psychotic-like experiences in adolescents: Findings from the ALSPAC cohort
Wallace, S., & Linscott, R. J. (2018) · Schizophrenia Research · doi:10.1016/j.schres.2017.10.028 · Cited by 9
Genetic contribution of catechol-O-methyltransferase in dorsolateral prefrontal cortex functional changes in the first episode schizophrenia
Kang, Y., Huang, K., Lv, Y., Zhang, W., Cai, S., Wang, Y., Wang, Q., Huang, L., Wang, J., & Tian, J. (2019) · Behavioural Brain Research · doi:10.1016/j.bbr.2019.02.012 · Cited by 9
Clarifying process versus structure in human intelligence: Stop talking about fluid and crystallized
Johnson, W., & Gottesman, I. I. (2006) · Behavioral and Brain Sciences · doi:10.1017/s0140525x06329032 · Cited by 9
Cocaine- and Amphetamine-Regulated Transcript Peptide (CART) Alleviates MK-801-Induced Schizophrenic Dementia-Like Symptoms
Borkar, C. D., Bharne, A. P., Balasubramanian, N., Sakharkar, A. J., Subhedar, N. K., & Kokare, D. M. (2018) · Neuroscience · doi:10.1016/j.neuroscience.2018.01.056 · Cited by 10
Illness Phase as a Key Assessment and Intervention Window for Psychosis
Kohler, C. G., Wolf, D. H., Abi‐Dargham, A., Anticevic, A., Cho, Y., Fonteneau, C., Gil, R. B., Girgis, R. R., Gray, D. L., Grinband, J., et al. (2022) · Biological Psychiatry Global Open Science · doi:10.1016/j.bpsgos.2022.05.009 · Cited by 8
Neurobiochemical Disturbances in Psychosis and their Implications for Therapeutic Intervention
Panov, G., & Panova, P. (2024) · Current Topics in Medicinal Chemistry · doi:10.2174/0115680266282773240116073618 · Cited by 8
Molecular evidence of altered stress responsivity related to neuroinflammation in the schizophrenia midbrain
Debs, S. R., Rothmond, D. A., Zhu, Y., Weickert, C. S., & Purves-Tyson, T. D. (2024) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2024.07.004 · Cited by 9
The 3rd Schizophrenia International Research Society Conference, 14–18 April 2012, Florence, Italy: Summaries of oral sessions
Abbs, B., Achalia, R. M., Adelufosi, A. O., Aktener, A. Y., Beveridge, N. J., Bhakta, S. G., Blackman, R. K., Bora, E., Byun, M. S., Cabanis, M., et al. (2012) · Schizophrenia Research · doi:10.1016/j.schres.2012.07.024 · Cited by 8
Independent support for corticopallidal contributions to schizophrenia-related functional impairment
Tarcijonas, G., Foran, W., Blazer, A., Eack, S. M., Luna, B., & Sarpal, D. K. (2019) · Schizophrenia Research · doi:10.1016/j.schres.2019.12.006 · Cited by 8
The Neurobiology of Schizophrenia
Bobo, W. V., Rapoport, J. L., Abi‐Dargham, A., Fatemi, S. H., & Meltzer, H. Y. (2015) · Wiley eBooks · doi:10.1002/9781118753378.ch19 · Cited by 8
TAAR1 Regulates Presynaptic Dopamine Function: Evidence From Preclinical Studies and a Phase 1b Trial in Patients With Schizophrenia
Howes, O. D., Vano, L. J., Petty, A. E., Rutigliano, G., Halff, E. F., Veronese, M., Kaar, S. J., Nordio, G., Lopes, E. F., Cragg, S. J., et al. (2025) · Biological Psychiatry · doi:10.1016/j.biopsych.2025.10.013 · Cited by 8
Knockdown of mortalin within the medial prefrontal cortex impairs normal sensorimotor gating
Gabriele, N., Pontoriero, G. F., Thomas, N., Shethwala, S., Pristupa, Z. B., & Gabriele, J. P. (2010) · Synapse · doi:10.1002/syn.20794 · Cited by 7
Transcriptomic Data Analysis Reveals a Down-Expression of Galectin-8 in Schizophrenia Hippocampus
Petralia, M. C., Ciurleo, R., Bramanti, A., Bramanti, P., Saraceno, A., Mangano, K., Quattropani, M. C. A., Nicoletti, F., & Fagone, P. (2021) · Brain Sciences · doi:10.3390/brainsci11080973 · Cited by 7
Applications of Clinical Dopamine Imaging
Lindsey, K. P., & Gatley, S. J. (2006) · Neuroimaging Clinics of North America · doi:10.1016/j.nic.2006.06.003 · Cited by 7
Reprint of: F-18Fluorodeoxyglucose positron emission tomography studies of the schizophrenia spectrum: The legacy of Monte S. Buchsbaum, M.D.
Hazlett, E. A., Vaccaro, D. H., Haznedar, M. M., & Goldstein, K. E. (2019) · Psychiatry Research · doi:10.1016/j.psychres.2019.06.014 · Cited by 7
Pathophysiology of Schizophrenia
Padmanabhan, J. L., & Keshavan, M. S. (2014) · Springer eBooks · doi:10.1007/978-1-4939-0656-7_4 · Cited by 7
Zehn Jahre funktionelle Magnetresonanztomographie in der Schizophrenieforschung
Tost, H., Meyer‐Lindenberg, A., Ruf, M., Demirak�a, T., Grimm, O., Henn, F. A., & Ende, G. (2005) · Der Radiologe · doi:10.1007/s00117-004-1154-1 · Cited by 7
Self-citation
Kv channel interacting protein 3 expression and regulation by haloperidol in midbrain dopaminergic neurons
Duncan, C. E., Schofield, P. R., & Weickert, C. S. (2009) · Brain Research · doi:10.1016/j.brainres.2009.09.045 · Cited by 7
Acute and Lifetime Stress and Psychotic Illness: The Roles of Reward and Salience Networks
Nudelman, J. L., & Waltz, J. A. (2022) · Journal of Psychiatry and Brain Science · doi:10.20900/jpbs.20220012 · Cited by 7
Analysis of networks in the dorsolateral prefrontal cortex in chronic schizophrenia: Relevance of altered immune response
Vera-Montecinos, A., Rodríguez‐Mias, R. A., Vila, È., Villén, J., & Ramos, B. (2023) · Frontiers in Pharmacology · doi:10.3389/fphar.2023.1003557 · Cited by 6
First episode psychosis with extrapyramidal signs prior to antipsychotic drug treatment
Honer, W. G., Lang, D. J., Kopala, L. C., MacEwan, G. W., Smith, G. N., Chen, E. Y. H., & Chan, R. C. K. (2011) · Chinese Science Bulletin · doi:10.1007/s11434-011-4738-y · Cited by 6
Cytokine pathway disruption in a mouse model of schizophrenia induced by Munc18-1a overexpression in the brain
Gil-Pisa, I., Cebrián, C., Ortega, J. E., Meana, J. J., & Sulzer, D. L. (2014) · Journal of Neuroinflammation · doi:10.1186/1742-2094-11-128 · Cited by 6
Die Glutamathypothese der Schizophrenie
Gudlowski, Y., & Gallinat, J. (2008) · Nervenheilkunde · doi:10.1055/s-0038-1627256 · Cited by 6
Haloperidol treatment downregulates DCC expression in the ventral tegmental area
Grant, A., Manitt, C., & Flores, C. (2014) · Neuroscience Letters · doi:10.1016/j.neulet.2014.05.030 · Cited by 6

Authors: Meyer-Lindenberg, A., Miletich, R. S., Kohn, P. D., Esposito, G., Carson, R. E., Quarantelli, M., Weinberger, D. R., & Berman, K. F.
Affiliations: National Institutes of Health (US)
ORCID: Carson, Richard E.
Quarantelli, Mario
Weinberger, Daniel R.
Berman, Karen Faith
Venue: Nature Neuroscience
Publisher: Springer Science and Business Media LLC
Published: 2002-01-28
Volume: 5
Issue: 3
Pages: 267-271
ISSN: 1097-6256 (ISSN-L)
1546-1726
DOI: 10.1038/nn804
OpenAlex: W2004729128
Cited by: 652
References: 50
Citations by year: 2026: 8 · 2025: 14 · 2024: 13 · 2023: 9 · 2022: 15 · 2021: 30 · 2020: 16 · 2019: 32 · 2018: 20 · 2017: 25 · 2016: 31 · 2015: 41 · 2014: 35 · 2013: 38 · 2012: 40
FWCI: 19.67
Type: journal article
Language: en
Open access: closed
Licence: www.springer.com/tdm (tdm)
Locations: Nature Neuroscience (publishedVersion)
PubMed (publishedVersion)
Topics: Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment
Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
Life Sciences › Neuroscience › Cognitive Neuroscience › Neural and Behavioral Psychology Studies
Keywords: schizophrenia, prefrontal cortex, striatum, dopamine signaling, dopamine uptake, regional cerebral blood flow, Wisconsin Card Sorting Test, prefrontal cortex activation
MeSH terms: Cerebrovascular Circulation, Corpus Striatum, Dihydroxyphenylalanine, Dopamine, Fluorine Radioisotopes, Humans, Neuropsychological Tests, Schizophrenia, Statistics as Topic, Synapses, Tomography, Emission-Computed, Prefrontal Cortex

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Reduced prefrontal activity predicts exaggerated striatal dopaminergic function in schizophrenia

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks